Brucellosis

Home | About EPMEDIC | Contact Information | What's New | Site Map

This site last updated on
Wednesday, 19 December 2001

Brucellosis

Calendar of Events
Programs
Medical Services
Legislation
Planning
Training
Equipment
Information Sharing

Incident Notification Protocol

Anthrax

Biological Agent Operational Data Chart

Medical Response to WMD

Response Planning

 

Biological Agent Patient Medical ManagementMedical Management of Biological Agent Patients

The following information contains adaptations and excerpts from the US Army Center for Health Promotion and Preventive Medicine (USACHPPM) Tech Guide 244, The Medical NBC Battlebook.

Medical Management of... | Biological Agent Mass Casualty Management | General Treatment Measures | Biological Agent Operational Data Chart | Anthrax | Brucellosis | Plague | Tularemia | Q Fever | Botulinum Toxin | T-2 Mycotoxin | Ricin | Smallpox

Characteristics. Brucellosis is a systemic zoonotic disease caused by one of four species of bacteria: Bucella melitensis, B. abortus, B suis, and B. canis; virulence for humans decreases somewhat in the order given. These bacteria are small gram-negative, aerobic, non-motile coccobacilli that grow within monocytes and macrophages. They reside quiescently in tissue and bone-marrow, and are extremely difficult to eradicate even with antibiotic therapy. Their natural reservoir is domestic animals, such as goats, sheep, and camels (B. melitensis); cattle (B. abortus); and pigs (B. suis). B. canis is primarily a pathogen of dogs, and only occasionally causes disease in humans. When used as a biological weapon, brucellae would most likely be delivered by the aerosol route; the resulting infection would be expected to mimic natural disease. Terrorist and partisans would most likely spread Brucellosis through contamination of dairy products.

Clinical Features. Brucellosis presents after an incubation period normally ranging from 3-4 weeks, but may be as short as 1 week or as long as several months. Clinical disease presents typically as an acute, non-specific febrile illness with chills, sweats, headache, fatigue, mylagia, arthralgia, and anorexia. Cough occurs in 15-25% of patients, but chest radiographs are usually normal. Complications include: sacroiliitis, arthritis, vertebral osteomyelitis, epididymo-orchitis, and rarely, endocarditis. B. melitensis may result in a 30-40% patient fatality rate.

Vaccine. Live animal vaccines are widely used. Killed and live attenuated human vaccines have been available in many countries but are of unproven efficacy. No approved human vaccine is available at this time.

Back to Top

[Home] [About EPMEDIC] [Contact] [What's New] [Site Map] Calendar of Events ] Programs ] Medical Services ] Legislation ] Planning ] Training ] Equipment ] Information Sharing ]

Emergency Preparedness Medical Information Center | P.O. Box 340239 | San Antonio, Texas 78234-0239

send an email to emrgncprepinfo@aol.com

Copyright © 2001.  |  Emergency Preparedness Medical Information Center  |  All rights reserved.